A highly sensitive, selective, and reliable analytical method has been developed and validated for characterization of asphalt fume generated under road paving conditions. A new approach was developed utilizing a microflow liquid chromatogram (LC) coupled to atmospheric pressure chemical ionization (APCI) of quadrupole/time-of-flight mass spectrometry (Q-TOF MS). A dynamic asphalt fume generation system was modified to provide consistent test atmospheres at simulated road asphalt paving conditions. Characterization of the asphalt fume test atmospheres included (1) determination of the uniformity of the aerosol distribution within the generator and exposure chamber; (2) quantitative detection of total extractable asphalt fume content by electron ionization of isotope dilution GC-MS; (3) use a photo ionization detector (PID) for on-line monitoring; and (4) identification of individual priority polycyclic aromatic hydrocarbons (PAHs) in the asphalt fume by selected ion monitoring GC-MS, and further clarification of important PAH by coupling microflow LC to Q-TOF MS. Total extractable asphalt fume components were quantified over the 5 day exposure. Sixteen individual priority PAHs were monitored and identified. These PHA's were detected at a trace level on filter fractions. By coupling microflow LC to APCI of Q-TOF MS, the new approach of collision-induced disassocation of fragmentation pathway leading to a characteristic fragmentation pattern for selected target analytes was used to further clarify the trace amount of PAHs present in simulated road paving asphalt fumes. These results demonstrate that asphalt fume compositions can be characterized and individual priority PAHs can be identified at trace levels using this developed method. Such a method is suitable for support of simulated occupational exposure for inhalation toxicity studies.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.